INKT
Price
$11.07
Change
+$0.70 (+6.75%)
Updated
Jul 24 closing price
Capitalization
56.05M
18 days until earnings call
Intraday BUY SELL Signals
KAPA
Price
$0.28
Change
-$0.02 (-6.67%)
Updated
Jul 24 closing price
Capitalization
6.1M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INKT vs KAPA

INKT vs KAPA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
INKT vs. KAPA commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a StrongBuy and KAPA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (INKT: $11.07 vs. KAPA: $0.28)
Brand notoriety: INKT and KAPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 29% vs. KAPA: 53%
Market capitalization -- INKT: $56.05M vs. KAPA: $6.1M
INKT [@Biotechnology] is valued at $56.05M. KAPA’s [@Biotechnology] market capitalization is $6.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileKAPA’s FA Score has 1 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • KAPA’s FA Score: 1 green, 4 red.
According to our system of comparison, KAPA is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 4 TA indicator(s) are bullish while KAPA’s TA Score has 4 bullish TA indicator(s).

  • INKT’s TA Score: 4 bullish, 5 bearish.
  • KAPA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KAPA is a better buy in the short-term than INKT.

Price Growth

INKT (@Biotechnology) experienced а +3.85% price change this week, while KAPA (@Biotechnology) price change was -8.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

INKT is expected to report earnings on Aug 12, 2026.

KAPA is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($56M) has a higher market cap than KAPA($6.1M). INKT YTD gains are higher at: -0.717 vs. KAPA (-59.859). KAPA has higher annual earnings (EBITDA): -5.71M vs. INKT (-12.67M). INKT has more cash in the bank: 9.53M vs. KAPA (3.68M). KAPA has less debt than INKT: KAPA (142K) vs INKT (5.73M). INKT (0) and KAPA (0) have equivalent revenues.
INKTKAPAINKT / KAPA
Capitalization56M6.1M918%
EBITDA-12.67M-5.71M222%
Gain YTD-0.717-59.8591%
P/E RatioN/AN/A-
Revenue00-
Total Cash9.53M3.68M259%
Total Debt5.73M142K4,032%
TECHNICAL ANALYSIS
Technical Analysis
INKTKAPA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signal:
Gain/Loss:
KAPA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGVC30.010.66
+2.25%
Natural Grocers BY Vitamin Cottage
UFI6.290.13
+2.11%
UNIFI
CHD97.641.45
+1.51%
Church & Dwight Co
AB37.200.05
+0.13%
AllianceBernstein Holding LP
GCDT0.47-0.01
-2.25%
Green Circle Decarbonize Technology Ltd

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been closely correlated with REVB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if INKT jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
+6.75%
REVB - INKT
66%
Closely correlated
-2.80%
KAPA - INKT
50%
Loosely correlated
-4.33%
RAIN - INKT
43%
Loosely correlated
-2.01%
CYPH - INKT
42%
Loosely correlated
-5.98%
PTHS - INKT
41%
Loosely correlated
-8.73%
More

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with INKT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
-4.33%
INKT - KAPA
50%
Loosely correlated
+6.75%
BGMS - KAPA
46%
Loosely correlated
+5.17%
ATHE - KAPA
25%
Poorly correlated
-3.32%
PHIO - KAPA
24%
Poorly correlated
-2.80%
AZTR - KAPA
24%
Poorly correlated
-0.55%
More